JapanStake
Retail Trade · Fiscal year end Mar 31

SUNDRUG CO.,LTD.

9989

株式会社サンドラッグ

FIGI BBG000DDGGX79989.T9989 JPCorp. no. 1012401000634

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥418.4 billion (+5.8% YoY), Ordinary income ¥22.9 billion (+9.9% YoY), Net income ¥15.3 billion (+7.0% YoY).

This periodYear on year
Revenue¥418.4bn+5.8%
Ordinary profit¥22.9bn+9.9%
Net profit to owners¥15.3bn+7.0%

From the securities report on EDINET, which states no forecast. History via /v1/companies/9989/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31
Revenue
¥842.5bn
Net income
¥31.4bn
ROE
11.3%
Equity ratio
60.1%
Dividend / share
¥131
Employees
7,457
Revenue · ¥bn
FY2022: ¥648.7bn 649 FY2022FY2023: ¥690.5bn 690 FY2023FY2024: ¥751.8bn 752 FY2024FY2025: ¥801.8bn 802 FY2025FY2026: ¥842.5bn 843 FY2026
Net income · ¥bn
FY2022: ¥23.9bn 23.9 FY2022FY2023: ¥25.7bn 25.7 FY2023FY2024: ¥29.1bn 29.1 FY2024FY2025: ¥30.8bn 30.8 FY2025FY2026: ¥31.4bn 31.4 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥842.5bn¥31.4bn¥475.5bn¥286.0bn11.3%¥268.36¥43.3bn
2025-03-31¥801.8bn¥30.8bn¥444.0bn¥269.7bn11.8%¥262.91¥41.2bn
2024-03-31¥751.8bn¥29.1bn¥420.2bn¥253.1bn11.9%¥249.07¥41.2bn
2023-03-31¥690.5bn¥25.7bn¥360.7bn¥236.3bn11.3%¥219.83¥37.4bn
2022-03-31¥648.7bn¥23.9bn¥325.8bn¥220.6bn11.2%¥204.02¥31.7bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %11.364.9
Ordinary margin0.054941.1
Equity ratio, %60.158.3
Revenue growth0.050850.6
Net income growth0.020937.7
Operating cash flow / assets0.091168.1
Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 0.3% held by other listed companies.

Results wording balance: +0.50. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥48.2bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥241m, 0.6% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/9989/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-26: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Drug Store, Discount Store. /v1/companies/9989/segments
Latest voting result: 2026-06-27 · 剰余金処分の件 · passed. /v1/companies/9989/voting

Ownership changes

All companies →

5% filings

Large shareholding reports on 9989
FiledFilerStakeChangeStated purpose
2026-07-23Iryu.Co.,Ltd.39.29%0.00pt—
2026-07-10Iryu.Co.,Ltd.39.29%0.00pt—
2026-06-05Orbis Investment Management Limited4.94%−1.09pt—
2026-05-12Orbis Investment Management Limited6.03%−1.09pt—
2026-04-07Orbis Investment Management Limited7.12%−1.13pt—
2025-04-07Orbis Investment Management Limited8.25%+1.07pt—
2024-10-22Orbis Investment Management Limited7.18%+1.03pt—
2023-11-22Orbis Investment Management Limited6.15%+1.02pt—
2023-09-01Orbis Investment Management Limited5.13%——

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
1 issues
Book value
¥40m
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
1
Held by listed cos.
12
HoldsBook valueShares vs. prior yearMutual
MatsukiyoCocokara & Co 3088¥40m0.0%both reports

Held by: KOBAYASHI PHARMACEUTICAL CO.,LTD. 4967, Lion Corporation 4912, ZERIA PHARMCEUTICAL CO., LTD. 4559, ARATA CORPORATION 2733, S.T.CORPORATION 4951, SUZUKEN CO.,LTD. 9987, MatsukiyoCocokara & Co 3088, SAGAMI RUBBER INDUSTRIES CO.,LTD. 5194, ZERIA PHARMCEUTICAL CO., LTD. 4559, ATSUGI CO., LTD. 3529, CREATE SD HOLDINGS CO.,LTD 3148, MINOYA Co., LTD. 386A and 1 more

Purposes, all holdings and mutual flags via /v1/companies/9989/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
株式会社イリュウ商事43,776,00037.42%
日本マスタートラスト信託銀行株式会社(信託口)11,493,0009.82%
株式会社日本カストディ銀行（信託口）5,798,0004.96%
individual holder4,238,0003.62%
individual holder3,113,0002.66%
ザ チェース マンハッタン バンク エヌエイ ロンドン エス エル オムニバス アカウント2,312,0001.98%
individual holder2,207,0001.89%
全国共済農業協同組合連合会2,069,0001.77%
JPモルガン証券株式会社1,769,0001.51%
株式会社日本カストディ銀行（信託口４）1,391,0001.19%

U.S. funds holding 9989

SEC Form N-PORT, reports to 2026-07-31

94 U.S. funds held 8,451,308 shares worth $199.1m.

FundSharesValue% of fundAs of
Goldman Sachs International Small Cap Insights Fund
Goldman Sachs Trust
1,950,500$46.3m0.649%2026-07-31
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
969,960$23.1m0.004%2026-07-31
Columbia Overseas Value Fund
COLUMBIA FUNDS SERIES TRUST
925,100$21.1m0.310%2026-05-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
665,537$15.6m0.005%2026-06-30
iShares Core MSCI EAFE ETF
iShares Trust
543,300$12.9m0.007%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/9989
GET /v1/companies/9989/financials
GET /v1/companies/9989/details
GET /v1/companies/9989/segments
GET /v1/companies/9989/voting
GET /v1/companies/9989/tender-offers
GET /v1/companies/9989/indicators
GET /v1/companies/9989/earnings-releases
GET /v1/events?ticker=9989
GET /v1/companies/9989/trades         
GET /v1/companies/9989/cross-holdings 
GET /v1/companies/9989/brief

Plans from $9 a month · Documentation